Futures of various stocks have seen a build-up in the October series with traders rolling over their bets from the September contracts, which expired on Thursday. A look at stock futures that have seen higher-than-average rollovers and their near-term outlook. Titan Company CMP: Rs 3,817 Rollover to October series: 97.5% Futures open interest change in … Read more
Ace investor late Rakesh Jhunjhunwala, often referred to as the Big Bull of Indian stock markets, passed away 2 years ago on this day and as investors remember him today on his second death anniversary, his investment philosophy will continue to inspire them. Jhunjhunwala died at the age of 62 in 2022 because of kidney … Read more
While Nifty ended with modest weak-on-weak gains of 0.4%, the truncated trading week was laden with top action where over three dozen companies from large, mid and smallcap segments witnessed prominent block deals worth Rs 40,543 crore on screen, which included both buying and selling. In the largecap segment, 15 companies witnessed significant block deals … Read more
Brokerage Macquarie maintained an outperform rating on Aurobindo Pharma, Morgan Stanley initiated coverage on Suzlon, CLSA upgraded Apollo Hospital and CLSA maintained a buy rating on Titan Company. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Aurobindo Pharma: Outperform | Target Rs 1,385Macquarie maintained an … Read more
Mumbai: Shares of Titan Company plunged 7.2% Monday after fourth-quarter results showed profitability is under pressure. Most analysts trimmed their price targets on the stock, but the forecasts still imply upside of 8-22% over Monday’s closing price of ₹3,281. Analysts said rising gold prices could dent demand for Titan’s products. “There is a notable and … Read more
Indian market is likely to consolidate on Friday tracking mixed global cues. The Nifty future closed negative with losses of 0.54% at 22,080 levels on Thursday. India VIX was up by 2.08% from 12.62 to 12.88 levels. On the options front, the maximum Call OI is placed at 22,500 and then towards 22700 strikes while … Read more
In the race of returns, gold appears to have left the S&P BSE Sensex behind by miles in 2024. The yellow metal has approximately given 13% returns on a year-to-date (YTD) basis as against a 4% gain delivered by India’s heartbeat index. In the 30-stock index, 10 have given returns superior to gold in 2024. … Read more
While gold has been treading a path of glory hitting fresh lifetime highs on a regular basis since the beginning of March, the performance of jewellery stocks have been less than inspiring. A data on 18 jewellery stocks with a market cap of Rs 100 crore or more, analysed by ETMarkets, showed that 15 stocks … Read more
Indian headline indices ended in the red on Saturday conceding their morning gains amid selling pressure in FMCG, IT and pharma sectors despite a good show by banks. The S&P BSE Sensex declined nearly 260 points while the Nifty50 closed below 21,600 level. Stocks that were in focus include names like Bharti Airtel rose more … Read more
Brokerage firm Citigroup maintained a buy on IGL, CLSA maintained a buy rating on Titan Company, Axis Capital initiated coverage on Rallis India to reduce and Jefferies maintained a buy rating on IndusInd Bank. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Citigroup on IGL: Buy| Target … Read more
